DSP5336-101

Clinical Trial Grant

Duke Scholars

Principal Investigator Harry Paul Erba Medicine, Hematologic Malignancies and Cellular Therapy

Administered By

Duke Cancer Institute

Awarded By

Sumitomo Dainippon Pharma Co.

Start Date

July 19, 2022

End Date

July 14, 2027

Administered By

Duke Cancer Institute

Awarded By

Sumitomo Dainippon Pharma Co.

Start Date

July 19, 2022

End Date

July 14, 2027